1. Psychometric validation of the Portuguese version of the Neuropathic Pain Symptoms Inventory
- Author
-
Erich Talamoni Fonoff, Joaci o. arauJo, H.H.S. Kaziyama, Gerson Ballester, Lyn T Yeng, Katia de Sá, Patrick Stump, Ricardo Galhardoni, Karine Azevedo São Leão Ferreira, Daniel Ciampi de Andrade, Manoel Jacobsen Teixeira, Didier Bouhassira, Telma Regina Mariotto Zakka, Abrahão F Batista, Carine M Nishimura, Pain Center, University of São Paulo (USP), Instituto do Câncer do Estado = Cancer Institute of the State of São Paulo (ICESP), Divisão de Neurologia e Epidemiologia, Universidade Federal da Bahia (UFBA), Coordenação de Pós-Graduação, Pesquisa e Extensão-Escola Bahiana de Medicina e Saúde Pública, Physiopathologie et Pharmacologie Clinique de la Douleur (LPPD), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), BMC, Ed., and Universidade de São Paulo = University of São Paulo (USP) more...
- Subjects
Male ,Psychometrics ,Neuropathic pain ,0302 clinical medicine ,Quality of life ,Pain assessment ,pain assessment ,030212 general & internal medicine ,Pain Measurement ,Aged, 80 and over ,General Medicine ,Neuropathic Pain Symptom Inventory ,Middle Aged ,language ,lcsh:R858-859.7 ,Female ,Neuropathic Pain Symptom Inventor ,Adult ,Validation study ,medicine.medical_specialty ,lcsh:Computer applications to medicine. Medical informatics ,Sensitivity and Specificity ,03 medical and health sciences ,medicine ,Humans ,Aged ,Quality of Life Research ,neuropathic pain ,Portugal ,business.industry ,Questionnaire ,Research ,questionnaire ,Public Health, Environmental and Occupational Health ,Reproducibility of Results ,medicine.disease ,language.human_language ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,Portuguese language ,Quality of Life ,Neuralgia ,Physical therapy ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Portuguese ,Factor Analysis, Statistical ,business ,030217 neurology & neurosurgery - Abstract
p. 1-6 Submitted by Edileide Reis (leyde-landy@hotmail.com) on 2014-02-18T14:17:09Z No. of bitstreams: 1 Abrahão F Batista.pdf: 280008 bytes, checksum: e084a734cde588dbe3c33d065e883844 (MD5) Approved for entry into archive by Flávia Ferreira (flaviaccf@yahoo.com.br) on 2014-11-28T16:03:05Z (GMT) No. of bitstreams: 1 Abrahão F Batista.pdf: 280008 bytes, checksum: e084a734cde588dbe3c33d065e883844 (MD5) Made available in DSpace on 2014-11-28T16:03:05Z (GMT). No. of bitstreams: 1 Abrahão F Batista.pdf: 280008 bytes, checksum: e084a734cde588dbe3c33d065e883844 (MD5) Previous issue date: 2011 Backgroud It has been shown that different symptoms or symptom combinations of neuropathic pain (NeP) may correspond to different mechanistic backgrounds and respond differently to treatment. The Neuropathic Pain Symptom Inventory (NPSI) is able to detect distinct clusters of symptoms (i.e. dimensions) with a putative common mechanistic background. The present study described the psychometric validation of the Portuguese version (PV) of the NPSI. Methods Patients were seen in two consecutive visits, three to four weeks apart. They were asked to: (i) rate their mean pain intensity in the last 24 hours on an 11-point (0-10) numerical scale; (ii) complete the PV-NPSI; (iii) provide the list of pain medications and doses currently in use. VAS and Global Impression of Change (GIC) were filled out in the second visit. Results PV-NPSI underwent test-retest reliability, factor analysis, analysis of sensitivity to changes between both visits. The PV-NPSI was reliable in this setting, with a good intra-class correlation for all items. The factorial analysis showed that the PV-NPSI inventory assessed different components of neuropathic pain. Five different factors were found. The PV-NPSI was adequate to evaluate patients with neuropathic pain and to detect clusters of NeP symptoms. Conclusions The psychometric properties of the PV-NPSI rendered it adequate to evaluate patients with both central and peripheral neuropathic pain syndromes and to detect clusters of NeP symptoms. more...
- Full Text
- View/download PDF